Acutaas Chemicals plans to increase its revenue by 25% in the fiscal year 2027 compared to the previous year, aiming to surpass the 33% growth achieved in FY26. The company's managing director is optimistic about meeting this target for the upcoming fiscal year.

Acutaas Chemicals reports a significant 40% year-on-year increase in Q4 revenue, reaching an impressive ₹4.2 billion – indicative of strong growth.

Acutaas Chemicals announces a final dividend of INR 2.5 per share, providing shareholders with the opportunity to receive a cash payout for the current period.

Acutaas Chemicals has announced a board meeting on April 30, 2026, to discuss and approve the Q4 and annual financial results for the fiscal year 2025-26. The meeting will also cover the final dividend recommendation and other business matters. Trading in Acutaas shares will remain suspended until May 2, 2026.